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Background:  Reducing obesity through effective behaviour change interventions is of 2 
key importance to prevent disabling and life-threatening conditions, particularly in 3 
individuals already at risk for morbidity. 4 
Purpose:  To assess the effects of behavioural interventions for obese adults with 5 
additional risk factors for morbidity on behaviour, weight and disease risk factors. 6 
Methods:  Systematic review of randomised controlled trials (RCTs).  Three electronic 7 
databases and three journals were searched for behavioural interventions (aimed at 8 
changing dietary intake and/or physical activity [PA]) for adults (mean BMI ≥30kg/m 2; 9 
mean age ≥40 years) with risk factors for morbidity, reporting follow-up data ≥12 10 
weeks. 11 
Results:  Forty-four RCTs met the inclusion criteria.  Behavioural outcomes, weight 12 
loss, and cardiovascular disease risk factors showed consistent modest improvements 13 
over time, especially for interventions targeting both diet and PA. 14 
Conclusion:  Behavioural interventions in at-risk populations showed positive effect 15 
tendencies on behaviour, weight and disease risk factors.  However, there is still ample 16 
room for improvement and future research should focus on identifying the most 17 
effective means of inducing dietary and PA behaviour change in this vulnerable 18 




The prevalence of obesity worldwide is both high and increasing [1] .  Obesity is 22 
associated with numerous comorbidities, including cardiovascular disease, type 2 23 
diabetes, hypertension, and certain cancers [2].  Behavioural interventions, aimed at 24 
influencing peoples’ dietary and/or PA behaviour, lead to weight loss and improved 25 
obesity-related risk factor profiles in individuals with excess weight [3-5]. 26 
When studying obesity interventions, it is important to consider the influence of 27 
additional risk factors for morbidity1
Previous systematic reviews evaluating the effects of behavioural interventions 33 
paid little attention to the most proximal target of behavioural weight-loss interventions, 34 
behaviour change itself [7].  As some intervention studies may not achieve significant 35 
weight loss or improvement in health risk factors, information about behavioural change 36 
is not only relevant but essential to our appraisal of the intervention.  Few systematic 37 
reviews examine the effectiveness of behaviour change interventions on behaviour, 38 
although evidence shows that dietary advice was found to lead to significant positive 39 
changes in self-reported fibre, fruit and vegetable, and saturated fat intake [8] and 40 
interventions promoting PA showed a significant moderate effect on self-reported PA 41 
[9]
 as interventions in individuals carrying these risk 28 
factors may be less effective [3].  Clinically obese populations with additional risk 29 
factors are one of the fastest growing patient populations.  Consequently, it is 30 
paramount to develop an understanding of the effects of behaviour change intervention 31 
on behaviour, weight and risk factor indicators in this population [6]. 32 
2
This systematic review extends the evidence base for behavioural obesity 43 
treatment by addressing the lack of behavioural analysis in the scrutiny of intervention 44 
effectiveness, and focuses attention on a population in need of intervention: obese 45 
adults with additional risk factors for morbidity. 46 
.  42 
METHODS 47 
Objectives 48 
To review the effects of behavioural interventions for obese adults with at least one 49 
additional risk factor for morbidity on behaviour (diet and PA), weight and risk factors.  50 
The effect of interventions on outcomes were compared for intervention groups (which 51 
                                                 
1 For further discussion of additional risk factors, see Mokdad et al. 2003[73] 
2 For the purpose of this review dietary intake and PA are considered examples of behaviours. 
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focused on changes in diet only, PA only, or both diet and PA) against control or less 52 
intensive intervention groups. 53 
Study inclusion criteria 54 
Types of studies.  Published RCTs providing ≥12 weeks follow-up data after 55 
randomisation.  No language limitations were specified. 56 
Types of participants.  Individuals with a mean/median BMI ≥30kg/m2.  Studies 57 
focused on adult obesity with a mean/median age of ≥40 as there is a rapid increase in 58 
obesity-related diseases including the metabolic syndrome [10] and type 2 diabetes [11] 59 
in middle age.  At least one additional risk factor for morbidity was required as this 60 
population is in greatest need of behaviour change to prevent long-term morbidity. 61 
Types of interventions.  Behavioural interventions aimed at changing diet and/or PA.  62 
For this review, interventions are classified by ‘diet only (D-only),’ ‘PA only (PA-63 
only),’ or ‘diet and PA (D-PA)’. 64 
Types of outcome measures.  The outcomes examined in this review were behaviour 65 
(i.e. objective or self-reported measures of diet and/or PA), weight and risk factors (total 66 
cholesterol, low density lipoprotein [LDL] cholesterol, high density lipoprotein [HDL] 67 
cholesterol, triglycerides, systolic and diastolic blood pressure [SBP and DBP], 68 
glycosylated haemoglobin [HbA1c] and fasting plasma glucose [FPG]). 69 
Search strategy for identification of studies 70 
Three electronic databases (MEDLINE, EMBASE, and PsycInfo) were searched for 71 
relevant studies using a comprehensive search strategy (available upon request).  Three 72 
journals (International Journal of Obesity, International Journal of Behavioural 73 
Medicine and Obesity Research) were searched by hand.  Reference lists of relevant 74 
review articles and of all included studies were searched for further studies. 75 
Methods of the review 76 
Identification of RCTs.  The first 200 references of RCTs were independently screened 77 
by two researchers (AA and SUD) and differences were resolved in discussion.  78 
Thereafter, the identification of studies was completed by one researcher (SUD). 79 
Quality assessment of studies.  Standard criteria for RCTs were used to appraise the 80 
methodological quality [12]. 81 
Data extraction.  Three researchers (AA, FFS and SD) extracted data for an initial three 82 
studies, and differences were resolved by discussion.  Thereafter, one researcher (SUD) 83 
extracted data for behaviour, weight and risk factors from the remaining studies. 84 
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Behavioural variables were assessed by a wide variety of measures (Table 1).  85 
Most studies focused on altering kilocalorie and fat intake, so these two outcomes 86 
became the main dietary focus. These measures are a proxy for change in dietary 87 
behaviour and used as dietary behavioural outcomes for the purpose of the current 88 
review.  All data entry into meta-analytic software, Review Manager (Version 4.2), was 89 
double checked one month after initial entry.   90 
Statistical analysis.  Where possible, a meta-analysis of the data was undertaken to 91 
determine the overall effect size.  Two different effect sizes were calculated depending 92 
on the outcomes under scrutiny [13].  Dietary fat and PA outcomes were assessed as 93 
standardised mean differences (SMDs), equivalent to Hedge’s adjusted g, as both 94 
outcome variables were reported on a variety of scales (see Table 1).   Kilocalorie, 95 
weight and disease risk factor outcomes were reported on the same scales and were 96 
combined as mean differences (MDs).  Change scores for dietary fat, kcal and PA 97 
outcomes were preferred and meta-analyses used a mixture of change from baseline and 98 
final value scores [13].  Weight and disease risk factor outcomes were analysed as 99 
change scores, and missing data was imputed using methods previously described [12].   100 
Ninety-five percent confidence intervals (CIs) were derived for effect sizes.  101 
Degree of inconsistency across studies was assessed using I2 [14].  I2 levels of ≥25% 102 
and ≥50% were interpreted as an indicator for moderate and substantial heterogeneity 103 
respectively.  It should be noted that I2  is dependent on the number of primary studies 104 
included and, in this case, there are some examples in which there are only a few 105 
primary studies.  I2 levels ≥50% were interpreted as an indicator for substantial 106 
heterogeneity.  Random effects methods for combining data were used reflecting the 107 
high heterogeneity in many of the meta-analyses.  Intention-to-treat data were used 108 
wherever available [13]. 109 
------------------------------Table 1 ------------------------------- 110 
------------------------------ Figure 1 ------------------------------- 112 
RESULTS 111 
Overall description of studies 113 
Forty-four studies met inclusion criteria (Table 1). 114 
Participants.  The mean age of participants was 55.0 (SD = 6.8) and the mean BMI was 115 
33.1 (SD = 2.2) ranging from 30.1 [15] to 38.8 [16].  In studies including participants of 116 
both genders, a small majority of women was reported (55%); eleven studies sampled 117 
women exclusively, and one study only men [17].  The majority of studies (n=21) 118 
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examined individuals with type 2 diabetes.  Others included individuals with risk 119 
factors such as hypertension (n=4), impaired glucose tolerance (n=3), or cardiovascular 120 
disease (n=2) (see Table 1 for details).  Two studies used the same intervention for two 121 
different populations and were treated as separate studies [18, 19].  The mean number of 122 
participants was 240 (SD = 502) ranging from 26 [20] to 3234 [21] with a mean dropout 123 
at completion of 16% (SD = 10.2). 124 
Intervention setting.  Most studies were conducted in the USA (n=27). Other countries 125 
were Canada (n=5), United Kingdom (n=5), the Australia (n=4), Finland (n=2) and 126 
Holland (n=1).   127 
Study Designs.  Twenty-seven trials allowed for comparison between a D-PA 128 
intervention against a usual care (UC) or waiting list control (WLC) group.  Six 129 
comparisons between D-only and six comparisons of PA-only against UC or WLC 130 
group were possible.  Altogether, seven trials for D-PA and four for D-only 131 
interventions allowed comparison of more intensive against less intensive treatments.  132 
Interventions were categorised as more intense when the behaviour change components 133 
within the intervention were delivered more frequently in one of two intervention 134 
groups. Similarly, if one intervention utilised more intervention components compared 135 
with the other it was classified as more intensive. 136 
Intervention duration and intensity.  The modal duration of interventions was 6 months 137 
(n=12), ranging from 2 [22, 23] to 36 months [24].  The modal duration of follow-up 138 
was 12 months (n=15) ranging from 3 [25] to 36 months [24].  Outcomes were 139 
commonly reported at distinct points in time - 3, 6, 12, 24, and 36 months - and 140 
intervention effects are summarised for these time points.  Where there were results 141 
reported for different time, these were ascribed to the nearest time point of common 142 
reporting. 143 
 Intensity of contact varied in intervention arms ranging from one contact every 144 
four months [26] to twice weekly [27].  The average contact per month was 4.6 (SD = 145 
6.5).  High intensity contact interventions tended to be exercise classes. 146 
Behavioural recommendations. Recommendations regarding dietary intake were 147 
categorised using Avenell et al.’s (2004) classifications.  Out of 51 different dietary 148 
treatment arms within the included trials, 20 provided general healthy eating advice3
                                                 
3 This includes studies where participants could choose their own healthy eating goals. 
, 18 149 
used a 600 kcal/day deficit or low fat reducing diet, 9 used a low calorie diet (1000-150 
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1600 kcal/day), two study arms used the Weight Watchers diet4
 PA recommendations varied in intensity, type, duration, frequency, and energy 153 
expenditure, and intensity was typically moderate.  Few interventions reported 154 
recommending a particular type of activity, with those that did favouring walking and 155 
regular daily activities.  The recommended activity duration was generally between 30-156 
45 minutes, three to four times per week.  Some recommendations specified targets for 157 
energy expenditure within a given period of time.  Many studies employed supervised 158 
exercise classes and groups (Table 1).  159 
, two provided no 151 
details, and one used the Ornish diet2 (Table 1). 152 
Quality of trials 160 
Randomisation.  Nineteen trials were identified as having made a good attempt at 161 
concealment of randomisation.  The remaining 25 studies stated that allocation was 162 
random without giving descriptions of procedures. 163 
Description of withdrawals.  Twenty-one studies provided numbers and reasons for 164 
study participant dropout and 20 studies mentioned the numbers of withdrawals only.  165 
Three studies stated withdrawals only but did not provide further details. 166 
Intention to treat.  Twenty-five studies claimed to use intention-to-treat (ITT) data 167 
analysis, and 13 studies did not state ITT procedures.  In six studies descriptions 168 
remained ambiguous. 169 
Blinding of outcome assessors.  The majority of trials (n=32) did not report blinding of 170 
outcome assessors.  Three studies stated that assessors were blinded, but did not provide 171 
further detail.  Nine studies that stated blinding assessors and described the blinding 172 
procedures. 173 
Behaviour change 174 
------------------------------Table 2------------------------------- 175 
Diet and PA Interventions vs. Usual Care/Waiting List Control.  Fifteen studies [21, 24, 176 
26-32, 36, 39-41, 45, 46] reported kilocalorie intake which allowed for meta-analysis at 177 
3, 6, 12, 18, 24 and 36 months (Table 3).  Reported decreases in favour of intervention 178 
compared with control groups were found at all time points and significant MDs were 179 
detected at 12, 18 and 36 months.  Evidence of heterogeneity in trial effects (i.e. 180 
differences in outcomes) was detected at 3 (I2 =46.6%) and 6 (I2 = 65.4%) months.  181 
Most studies reported outcomes at 6 and 12 months.  Three out of 8 studies [30, 45, 46] 182 
                                                 
4 It was felt that Weight Watchers and Ornish diets did not fit within the Avenell et al. (2004) categories. 
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reported significant differences in kilocalorie intake between intervention and control 183 
groups at 6 months, and 3 out of 10 studies [21, 24, 45] at 12 months. 184 
Eighteen studies [21-24, 26-32, 35, 39-41, 43, 45, 46] reported enough detail on 185 
fat intake to allow meta-analysis at 3, 6, 12, 18, 24 and 36 months (Table 3).  Consistent 186 
decreases in fat intake in intervention compared with control groups with significant 187 
SMDs at 3, 12, 18 and 24 months respectively.  Heterogeneity was found at 3, 6, 12 and 188 
24 months (I2 59.9% – 93.1%).  Most studies reported outcomes at 6 and 12 months 189 
with 7 [21, 30, 35, 40, 43, 45, 46] out of 13 studies and 5 [22, 24, 27, 29, 40] out of 17 190 
studies reporting significant between-group changes respectively.  At 12 months one 191 
study found a significant decrease in fat intake in the control group compared with the 192 
intervention condition [35]. 193 
Eighteen studies [16, 22, 24, 26-31, 33-36, 38-40, 45, 46] reported PA outcomes 194 
in enough detail to allow meta-analysis at 3, 6, 12, 18, 24 and 36 months (Table 3).  195 
Positive SMDs were reported at all points in time with significant PA increases between 196 
intervention compared with controls at 3, 6 and 12 months.  Heterogeneity of trial 197 
effects was found at 3, 6, 12 and 24 months (I2 54.8 – 73%).  The majority of studies 198 
reported outcomes at 6 and 12 months with 7 [16, 30, 35, 39, 40, 43, 45] out of 12 199 
studies, and 6 [27, 31, 36, 39, 40, 45] out of 10 studies respectively  inducing significant 200 
between-group PA differences.  201 
Dietary Interventions vs. Waiting List Control/Usual Care.  Four studies [17, 18, 32, 202 
45] reported dietary outcomes which could be included in meta-analysis at 3, 6, 12 and 203 
24 months (Table 3).  Significant decreases in kilocalorie intake between intervention 204 
and control groups were detected at 6, 12 and 24 months.  Despite significant changes 205 
in pooled outcomes at 12 months, only one study out of four [45] found a significant 206 
between-group difference in kilocalorie intake. 207 
 Changes in fat intake were reported in enough detail by three studies [18, 45, 47] 208 
to allow meta-analysis at 3, 6, 12, and 24 months (Table 3).  Significant intervention 209 
effects could be detected at 12 and 24.  Heterogeneity was detected at 6 (I2 = 76.1%) 210 
and 12 (I2 = 53.9%) months.  Significant between-group changes in fat intake were 211 
reported for all studies except one at 3 months [47] and one at 12 months [45] 212 
respectively. 213 
PA Interventions vs. Waiting List Control/Usual Care.  Seven studies [15, 20, 30, 45, 214 
50-52] reported PA change outcomes that allowed meta-analysis at 3, 6, 12 and 24 215 
months. Significant SMDs were found at 6 and 12 months.  At most time points 216 
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significant differences between intervention and control groups were reported with 2 217 
[15, 52] out of 2 showing significant between-group PA differences at 3 months, and 3 218 
[30, 45, 51] out of 5 at 6 months, and 2 [20, 45] out of 3 at 12 months.  219 
Intensive vs. Less Intensive Interventions.  Three studies [19, 47, 58] allowed the 220 
investigation of an intensive against a less intensive D-only intervention.  Meta-analysis 221 
at 3 and 12 months revealed no significant changes in kilocalorie intake in the one study 222 
including two samples providing enough details at those time points [19].  A significant 223 
between-group difference in favour of the intensive intervention was reported in one of 224 
the two samples.  Changes in fat intake were reported to differ significantly in one study 225 
consisting of two samples [19].  A further study of an intense dietary intervention 226 
compared with a less intense one found no effects of changes in fat intake at 3 and 6 227 
months [47]. 228 
 Ten studies [25, 32, 36, 45, 46, 53-56, 58] allowed the investigation of an 229 
intensive against a less intensive D-PA intervention.  None of these studies reported 230 
significant differences between groups for kilocalorie intake at any point in time.  231 
Furthermore, only one intervention significantly changed fat intake at 6 and 18 months 232 
[46], and one intervention significantly changed PA at 3 months [58] in favour of the 233 
intensive intervention.   234 
Weight change 235 
------------------------------Table 3 ------------------------------- 236 
------------------------------Figure 2------------------------------- 237 
Diet and PA Interventions vs. Waiting List Control/Usual Care.  Twenty-five  238 
[16, 21, 22, 24, 26-46] studies reported weight outcomes in sufficient detail to allow 239 
meta-analysis at 3, 6, 12, 24 and 36 months (Table 2).  At all time points weight 240 
changes were significantly different between intervention and control groups with the 241 
exception of 18 months.  Effects at all points in time were heterogeneous (I2 = 68.3–242 
95.0%) with the exception of 24 months (Figure 2).  Most studies reported outcomes at 243 
6 and 12 months with 10 [21, 28, 30, 32, 35, 40, 42, 43, 45, 46] out of 15 at 6 months 244 
and 8 [21, 24, 26, 27, 29, 32, 40, 45] out of 15 studies reporting significant between 245 
group differences in weight respectively.   246 
Diet Interventions vs. Waiting List Control/Usual Care.  Six studies [18, 32, 45, 47-49] 247 
reported changes in weight allowing meta-analysis at 3, 6, 12, and 24 months (Table 2).  248 
Differences in weight loss between intervention and control groups were significant at 249 
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3, 6, and 12 months (Figure 2).  Heterogeneity in the data was found at 3, 6, and 12 250 
months (I2 = 71.9% - 84.8%). 251 
PA Interventions vs. Waiting List Control/Usual Care.  Seven studies [15, 20, 30, 45, 252 
50-52] reported weight outcomes that could be meta-analysed at 3, 6, 12 and 24 months 253 
(Table 2).  The MD for weight change was significant only at six months with evidence 254 
for heterogeneity in the data (I2 = 83.5%).  Few studies reported non-significant 255 
differences at 3, 12 and 24 months (Figure 2). 256 
Intensive vs. Less Intensive Interventions.  Eleven studies allowed comparisons between 257 
intensive and less intensive interventions [19, 25, 32, 36, 46, 47, 53-57] at various 258 
points in time.  Intensive interventions, irrespective of whether the intervention 259 
consisted of a D-only or D-PA intervention, tended to induce greater MD for weight 260 
than the less intensive intervention groups (Table 2).  Significant changes were noted at 261 
12 and 16 months for D-only and at 3 months for D-PA studies.  262 
Risk factor change 263 
------------------------------Table 5------------------------------- 264 
------------------------------Table 6------------------------------- 265 
------------------------------Table 7------------------------------- 266 
Diet and PA Interventions vs. Waiting List Control/Usual Care.  Twenty studies [21, 267 
24, 26-33, 35-40, 42, 43, 45, 46] reported outcomes with respect to changes in at least 268 
one risk factor (Table 5).  Most studies provided outcome data at 3, 6, 12 and 24 269 
months.  Risk factor changes generally showed beneficial trends at various points in 270 
time.  At 3 months significant changes were found in total cholesterol, triglycerides and 271 
SBP.  At 6 months DBP, SBP and FBG showed significant improvements, with both 272 
SBP and DBP also showing significant differences between intervention and control 273 
groups at 12, 24 and 36 months.  Furthermore, triglycerides as well as HbA1c showed 274 
improvements at 12 months.  At 18 months LDL cholesterol was found to be 275 
significantly different in only one study [46] and at 24 months the only measure that 276 
was significantly improved was triglycerides.  The only study reporting outcomes at 36 277 
months displayed significant HbA1c improvement [24].  Overall, significant 278 
improvements were found in all risk factors with the exception of HDL cholesterol.  279 
The most consistent improvements were found in SBP and triglycerides.  280 
Diet Interventions vs. Waiting List Control/Usual Care.  Five studies [18, 32, 45, 47, 281 
49] provided data for at least one risk factor, which could be analysed at 3, 6, 12 and 24 282 
months (Table 6).  Risk factors generally showed tendencies towards improvement.  At 283 
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3 months significant improvements occurred in total cholesterol, triglycerides and SBP.  284 
SBP, DBP and FBG showed no significant differences compared with controls at 6 285 
months (Table 6).   286 
PA Interventions vs. Waiting List Control/Usual Care.  Six studies [15, 20, 30, 45, 51, 287 
52]  reported risk factor outcomes at least once allowing meta-analysis at 3, 6, 12, and 288 
24 months (Table 7).  Changes in risk factors due to PA-only interventions were less 289 
consistent when compared with D-PA and D-only interventions and no significant 290 
effects could be detected. 291 
Effects of Intensive vs. Less Intensive Interventions.  Comparison of intensive and less 292 
intensive interventions found a lack of significant differences with regard to risk factors. 293 
DISCUSSION 294 
The current systematic review assessed intervention effects on behaviour, as well as 295 
weight and disease risk factors.  When interpreting the results obtained in this review 296 
shortcomings should be taken into account.  Short-term outcomes (3 months) as well as 297 
long-term outcomes (24 months onwards) are based on a limited number of studies. 298 
Dietary and PA behaviours were reported using a variety of different measurements.  In 299 
particular, difficulties with self-reported outcomes and unreliable measures have been 300 
highlighted in the literature before [8, 59] and might have had an impact on the current 301 
findings.  Analyses of D-only, PA-only, and intensive vs. less intensive interventions 302 
were somewhat limited due to small number of studies which met inclusion criteria.  It 303 
should also be considered that some of our measures for heterogeneity were based on 304 
few primary studies and this can reduce the clinical relevance of findings.  The 305 
methodological quality of some of the studies that met inclusion criteria displayed room 306 
for improvement judged by study reportage.  The majority of studies did not to report 307 
on features such as the method of randomisation, or reasons for participant dropout.  308 
Nearly half of the studies failed to report whether the analysis was intention-to-treat.  309 
Blinding of outcome assessors was rarely described.  310 
We were unable to determine which manipulations were the active and 311 
successful ingredients within the studies [60].  We grouped the studies by their 312 
behavioural targets but this does not specify how interventions successfully change 313 
these behaviours and why some interventions were more effective than others [61].  314 
More research is needed to determine which specific aspects of behavioural 315 
interventions facilitate significant change in behaviour and subsequent physiological 316 
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outcomes, thereby explaining some of the significant heterogeneity typically 317 
encountered in systematic review of behaviour interventions, including the current one.  318 
The underlying model on the effect of behaviour change interventions postulates 319 
that weight, disease risk factors and health are all influenced through mediating 320 
behavioural effects [62].  To our knowledge this review is the first one to include 321 
behavioural dietary and PA effects alongside weight and risk factor changes in obese 322 
adults carrying additional risk factors.  Results indicated that behavioural interventions 323 
are successful at significantly changing behavioural outcomes to moderate degrees in 324 
both dietary and PA behaviours over consistent periods of time.  The magnitude of 325 
behavioural effects was modest.  The greatest reported reductions in MD of kilocalorie 326 
intake for D-PA interventions and D-only interventions were -138 kcal and -360 kcal at 327 
12 and 6 months respectively.  Given that a common aim of many dietary 328 
recommendations is the reduction of kilocalorie intake by 600 kilocalories per day, the 329 
observed changes suggest that many participants struggeled to adhere to dietary 330 
prescriptions.  Similar findings apply to modest dietary fat outcome effect sizes.  A 331 
previous systematic review in overweight/obese individuals without additional risk 332 
factors found similarly modest significant effects of dietary advice on fibre, fat and 333 
saturated fat intakes [8].  334 
An interesting pattern emerges when comparing the magnitude of behavioural 335 
intervention effects across different types of studies.  Compared against respective 336 
control conditions, behavioural D-PA study effects tended to be greater in magnitude in 337 
studies aimed at changing either of the behaviours in isolation when compared with 338 
studies that focused on diet and PA at the same time.  This finding suggests that 339 
behaviour change effects are greater when focusing on only one kind of behaviour, as 340 
compared with both diet and PA behaviours at the same time.  However, studies 341 
focusing on dietary and PA behaviours simultaneously lead to greater long-term weight 342 
loss than D-only or PA-only studies.  It might be the case that changing two behaviours 343 
at the same time decreases the magnitude of change due to participants’ limited self-344 
regulatory resources [63].  However, longer-term behaviour change maintenance might 345 
be upheld through focussing the attention and direction of behaviour change on both 346 
behaviours that facilitate weight loss.  Using dietary and PA interventions encourage a 347 
coherent change in one’s lifestyle behaviours towards behaving healthily. 348 
Obtained weight loss findings are consistent with previous systematic reviews 349 
[3, 12].  All types of studies successfully produced some weight loss in intervention 350 
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compared with control groups.  Weight loss patterns over time in D-PA, D-only and 351 
PA-only studies appeared to be similar.  Greatest weight loss was found at six months, 352 
with weight regain thereafter, echoing previous systematic review evidence [3] and 353 
underlining the difficulty of permanent lifestyle change [64] in obese adults with 354 
additional risk factors. 355 
The magnitude of weight loss appeared to differ between intervention types. 356 
Initial weight loss was greatest for D-only interventions, PA-only interventions showed 357 
the weakest effects on weight, with the only significant effects found at 6 months.  358 
Despite superior weight loss at 6 months by D-only interventions, subsequent time 359 
points showed weight loss advantages in favour of a combination of diet and PA 360 
interventions.  After 12 months the only study type found to produce significant 361 
differences in weight loss were interventions targeting changes in diet and PA.  362 
Differences in magnitude of weight loss over time between interventions have 363 
been documented by previous research.  Avenell et al (2004) found that interventions 364 
focusing on D-only led to greater MD in weight loss at 12 months compared with 365 
studies that focused on both diet and PA, with a reverse of this trend at later time points.  366 
Furthermore, a systematic review of RCTs of PA interventions found that the union of 367 
PA with dietary interventions led to a significant increase in weight loss compared with 368 
D-only interventions [65].  Previous literature has also indicated that PA-only typically 369 
has not been significantly more effective than D-only interventions in short-term weight 370 
loss [66].  These findings point to the importance of PA in the maintenance of initial, 371 
dietary induced weight loss [64, 67].  Studies using more intensive interventions 372 
produced greater weight loss.  This is the case for D-PA, as well as for D-only 373 
interventions. 374 
Comparing the magnitude of weight lost in the current review to other published 375 
meta-analyses with most trials not recruiting individuals carrying additional risk factors 376 
[3, 12, 68, 68], it appears that the weight lost in our studies is less.  This difference in 377 
the magnitude of weight loss according to the criteria of additional risk factors holds 378 
true for D-only interventions [12], PA-only interventions [65] and intensive compared 379 
with less intensive interventions [69]. 380 
With regard to changes in disease risk factors, these displayed similar patterns to 381 
weight loss outcomes.  All types of interventions that could be compared with control 382 
groups demonstrated a tendency towards improving various risk factors at some point in 383 
time.  However, the types of risk factors affected, as well as the magnitude and 384 
 15 
consistency of risk factor change, tended to differ according to intervention type.  D-385 
only interventions induced significant changes in total cholesterol, triglycerides, blood 386 
pressure and FPG in intervention compared with control conditions.  Overall, changes 387 
tended to occur at 3 and 6 months, mirroring weight loss.  Triglycerides seemed to show 388 
consistent beneficial trends at all points in time.  Similarly, total and LDL cholesterol 389 
showed trends towards significant improvements at all time points for D-only 390 
interventions.  In comparison, PA-only interventions and intensive compared with less 391 
intensive interventions were not successful at inducing risk factor changes.   392 
The greatest changes in risk factors were achieved by interventions that targeted 393 
both diet and PA. These changes tended to peak in magnitude at 12 months.  Similar to 394 
D-only interventions, triglycerides tended to show consistent positive improvements in 395 
combination interventions.  Furthermore, blood pressure seemed to show consistent and 396 
mostly significant improvements over time.  Unlike D-only interventions, the 397 
combination of diet and PA induced significant improvements in HbA1c. 398 
CONCLUSION 399 
Overall, the findings of this systematic review extend the evidence of behaviour change 400 
intervention effectiveness [8, 12, 70] and confirm the usefulness of this approach in 401 
populations carrying additional risk factors.  Improvements in behaviour , weight, and 402 
disease risk factors were recorded for all types of reviewed behaviour change 403 
interventions.  Changes tended to be greatest at around 6 months.  Behavioural changes 404 
were modest and tended to be greater in studies focusing solely on a single behaviour 405 
rather than both.  Interventions focusing on diet and PA simultaneously showed the 406 
greatest improvements in terms of weight loss and disease risk factor change.  However, 407 
most consistent beneficial effects over time regarding behaviourn weight and disease 408 
risk factors were found in D-PA studies.  The current review suggests that behavioural 409 
interventions in at risk populations showed positive effect tendencies.  Future research 410 
should focus on identifying the most effective means of inducing dietary and PA 411 
behaviour change.  412 
 413 
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Table 1 Details of included randomised controlled trials. 






Comorbidity: type 2 diabetes. 
Sex: 52 women, 12 men. 
Age mean(SD) years: (a) 62.4(5.9) (b) 61(5.7). 
BMI mean kg m-2: (a) 33.9 (b) 34.9. 
Weight mean(SD) kg: (a) 93.3(18.6) (b) 94.9(20.1).  
(a) Group counselling intervention.  Diet:  <30% from fat, ~55-60% kcal from 
carbohydrate, 12-20% from protein.  Activity: moderate physical activity ≥3 
days/week.  Other: weight loss of ≥4.5kg at the rate of ≤0.9/week. 
(b) Usual care.   
Allocated: (a) 32 (b) 32. 
% dropout: (a) 6.25% (b) 21.9% at 6 months. 
Possible comparisons: D-PA vs. UC. 
Follow-up(s): 3 & 6 
months. 
Outcomes: weight, total 
cholesterol, LDL, HDL, 
TGs, HbA1c, SBP, 
DBP, kcal, fat (% kcal), 
PASE. 





Comorbidity: type 2 diabetes. 
Sex: all men. 
Age mean(SD) years: (a) 54.3(9.4) (b) 54.2(7.4) (c) 
54.9(9.3). 
BMI mean(SD) kg m-2: (a) 31.2(3.4) (b) 31.1(3.7) (c) 
32.7(2.4). 
Weight mean(SD) kg: (a) 96.7(11.4) (b) 97.2(13.5) (c) 
101.4(11.9). 
Prior to randomisation all patients underwent 2 weeks of dietary stabilisation 
(1400-1700 kcal/day, 50% kcal from carbohydrate, 30% kcal from fat). 
(a) Liquid meal replacement (Modifast). Diet: 1000 kcal/day on 4 days/week, 
1400-1700 kcal/day on other three days. 
(b) Food provision. Diet: 6900 kj/day (1650 kcal/day, 51% of energy from 
carbohydrate, 20% from protein and 29% from fat). 
(c) Usual care.   
Allocated: (a) 20 (b) 17 (c) 14. 
% dropout: 47.1% for all groups combined at 18 months. 
Possible comparisons: D vs. UC. 
Follow-up(s): 12 weeks 
& 18 months. 
Outcomes: weight, total 
cholesterol, LDL, HDL, 
TGs, HbA1c, kcal. 
Blonk 1994  
[53] 
Location: Holland. 
Comorbidity: type 2 diabetes. 
Sex: (a) 18 women, 9 men (b) 16 women, 10 men. 
Age mean(CI) years: (a) 59.0(42.0, 69.0) (b) 58.5(29.0, 
70.0). 
BMI mean(CI) kg m-2: (a) 31.3(27.2, 44.3) (b) 
32.8(27.9-45.8). 
Weight mean(CI) kg: (a) 92.3(69.3, 120.8)  (b) 
87.8(65.2, 158.3). 
(a) Comprehensive program.  Diet: 500kcal deficit, minimum intake of 1000 
kcal, 30% kcal from fat, 50-55% kcal from carbohydrate, 25g fiber, <300mg/day 
cholesterol, and 15% kcal from protein.  Activity: scheduled exercise sessions 
twice/week fading out over time. 
(b) Conventional programme.  Diet: same as (a)  Activity: scheduled exercise 
sessions and exercise every day at home and increase in regular daily activities.   
Allocated: (a) 27 (b) 26. 
% dropout: not given. 
Possible comparisons: Intensive vs. less intensive (D-PA). 
Follow-up(s): 2, 4, 6, 8, 
12, 14, 16, 18, 20, 22 & 
24 months. 
Outcomes: weight, total 
cholesterol, LDL, HDL, 







Sex: (a) 34 women, 21 men (b) 29 women, 25 men (c) 
11 women, 13 men. 
Age mean(SD) years: (a) 48.5(1.2) (b) 46.6(1.2) (c) 
47.2(1.8). 
BMI mean(SD) kg m-2: (a) 32.1(4.0) (b) 32.8(4.0) (c) 
32.6(5.1). 
Weight mean(SD) kg: (a) 93.3(17.7)  (b) 95.4(14.5) (c) 
94.0(17.3). 
(a) Weight management group.  Diet: 5021J (1200 kcal) for women, 6276J 
(1500 kcal) for men, 15-20% of energy from fat.  Activity: scheduled and 
supervised exercise sessions 4-5 times/week   Other: 0.5-1kg weight loss/week. 
(b) Exercise group.  Activity: same as weight management group 
(c) Waiting list control group. 
Allocated: (a) 55 (b) 54 (c) 24. 
% dropout: (a) 16% (b) 19% (c) 8% at 6 months. 
Possible comparisons: D-PA vs. WLC; PA vs. WLC. 
Follow-up(s): 6 months. 
Outcomes: weight, 
SBP, DBP, FPG, kcal, 
fat (g), treadmill time. 
Burke 2007 Location: Perth, Australia. (a) Lifestyle programme. Diet: DASH diet low in fat (<30% kcal from fat, 10% Follow-up(s): 4 & 12 
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Study ID Participants Interventions Outcomes 
[29] Comorbidity: hypertension (drug treated) 
Sex: (a) 67 women 56 men (b) 67 women, 51 men 
Age mean(SD) years: (a) 57.1(7.2) (b) 55.5(7.5) 
BMI mean (SD) kg m-2: (a) 30.4(2.9) (b) 29.7(2.5) 
Weight mean(SD) kg: (a) 86.7(12.4) (b) 84.2(10.8) 
kcal from saturated fat), > fruit & vegetables, < salt & sugar, ≥ 4 fish 
meals/week, ≤ two standard drinks/day.  Activity: accumulate ≥30 min of MIPA 
on most days, increase incidental activity.  Other: decrease baseline weight by 5-
10% over 4 months. 
(b) Usual care. 
Allocated: (a) 123 (b) 118 
% dropout: (a) 17% (b) 24% 
Possible comparisons: D-PA vs. UC. 
months 
Outcomes: weight, 
SBP, DBP, kcal, fat (% 






Gender: all female. 
Age mean(SD) years: (a) 55.1(8.3) (b) 54.3(7.8). 
BMI mean kg m-2: (a) 37.8(5.8) (b) 35.1(5). 
(a) Lifestyle change.  Diet & Activity: LEARN program recommendations [71]. 
(b) Lifestyle change + Self-control skills.  Diet & Activity: same as (a) (only 
behavioural techniques differ). 
Allocated: (a) 21 (b) 23. 
% dropout: (a) 14.3% (b) 17.4% at 12 months. 
Possible comparisons: Intensive vs. less intensive (D-PA). 
Follow-up(s): 6 & 12 
months. 
Outcomes: weight, total 
cholesterol, LDL, HDL, 
TGs, SBP, DBP, FPG, 
kcal, fat (% kcal), 
treadmill time (sec). 
Clark 2004  
[22] 
Location: UK. 
Comorbidity: type 2 diabetes. 
Sex: 42 women, 58 men. 
Age mean years: 59.5. 
BMI mean (SD) kg m-2: (a) 32.40(4.49) (b) 
31.30(5.01). 
Weight mean(SD) kg: not given. 
(a) Lifestyle intervention.  Diet: Self selected goal(s) for lifestyle change.  
Activity: Self selected goal(s) for lifestyle change. 
(b) Usual care group. 
Allocated: (a) 50 (b) 50. 
% dropout: (a) 8% (b) 4% at 52 weeks. 
Possible comparisons: D-PA vs. UC. 
Follow-up(s): 3 & 12 
months. 
Outcomes: weight, total 
cholesterol, LDL, HDL, 
TGs, HbA1c, FHQ 






Comorbidity: type 2 diabetes. 
Sex: 152 women, 162 men. 
Age mean(SD) years: (a) 61.3(9.7) (b) 61.8(11.0). 
BMI mean(SD) kg m-2: (a) 30.8(5.3) (b) 30.6(5.7). 
Weight mean(SD) kg:  (a) 83.2(14.5) (b) 82.8(17.6). 
(a) X-PERT programme.  Diet: Recommendations based on the British Nutrition 
Foundation’s ‘Balance of Good Health’.  Activity: Exercise on prescription 
scheme (individual exercise recommendations from GP). 
(b) Control group. 
Allocated: (a) 157 (b) 157. 
% dropout: (a) 4.5% (b) 10.2%. 
Possible comparisons: D-PA vs. UC. 
Follow-up(s): 4 & 14 
months. 
Outcomes: weight, total 
cholesterol, LDL, HDL, 
TGs., HbA1c, SBP, 
DBP, kcal, fat (% kcal), 
Summary of self care 







Comorbidity: elevated fasting and post-load plasma 
glucose concentrations. 
Sex: (a) 737 women, 345 men (b) 710 women, 363 
men (c) 747 women, 335 men. 
Age mean(SD) years: (a) 50.6(11.3) (b) 50.9(10.3) (c) 
50.3(10.4). 
BMI mean(SD) kg m-2: (a) 33.9 (6.8) (b) 33.9(6.6) (c) 
(a) Lifestyle intervention.  Diet: 500-1000 kcal/day deficit, 25% kcal from fat.   
Activity: ≥700 kcal/week (equivalent to 150min of MPA).  Other: 7% weight 
loss of initial body weight. 
(b) Metformin group.  Other: 850mg of metformin daily. 
(c) Placebo control group. 
Allocated: (a) 1079 (b) 1073 (c) 1082. 
% dropout: “92.5% of participants had attended a scheduled visit within 
previous six months”. 
Follow-up(s): 6, 12, 18, 
24, 30, 36, 42, & 48 
months. 
Outcomes: weight, 
HbAc1, FPG, kcal, fat 
(% kcal). 
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34.2(6.7). 
Weight mean(SD) kg: (a) 94.1(20.8) (b) 94.3(19.9) (c) 
94.3(20.2). 




Comorbidity: breast cancer. 
Sex: all women. 
Age mean(SD) years: 51.7(8.4). 
BMI mean(SD) kg m-2: (a) 35(1.2) (b) 35.5(1.1) (c) 
36.8 (8) (d) 34.9(1.2). 
Weight mean(SD) kg: (a) 95.5(5) (b) 91.4(2.7) (c) 
100.5(5) (d) 95(3.6). 
(a) Weight watchers group.  Diet: Weight Watchers prescriptions. 
(b) Individualised group.  Diet: 500-1000kcal/d deficit, 20-25% kcal from fat.  
Activity: 30-45 min/d of MPA most days.  Other: decrease of 10% of baseline 
weight over 6 months. 
(c) Comprehensive group.  Diet: Weight Watchers prescriptions.  Activity: 30-45 
min/d of MPA most days.  Other: decrease of 10% of baseline weight over 6 
months. 
(d) Control group. 
Allocated: (a) 11 (b) 13 (c) 11 (d) 13. 
% dropout: (a) 27.3% (b) 30.8% (c) 9.1% (d) 7.7% at 12 months. 
Possible comparisons: D-PA vs. UC., Intensive vs. less intensive (D-PA, D 
only) 
Follow-up(s): 3, 6, & 
12 months. 
Outcomes: weight, total 
cholesterol, LDL, HDL, 






Comorbidity: One or more of the following: diabetes, 
hypertension, dyslipidemia, smoking, or BMI >25 
anthropometric measurements. 
Sex: 124 women, 30 men. 
Age mean(SD) years: (a) 52.2(5.2) (b) 53.4(4.8). 
BMI mean(SD) kg m-2: (a) 33.3(7.8) (b) 34.1(7.7). 
Weight mean(SD) kg: not given. 
(a) Personal Health Planning group.  Diet & Activity: change of behaviours 
linked to cardiovascular risk (e.g. “focus of commitment to healthier behaviours” 
or “education on the topics of nutrition, PA…”). 
(b) Control group. 
Allocated: (a) 77 (b) 77. 
% dropout: (a) 27.3% (b) 14.3% at 10 months. 
Possible comparisons: D-PA vs. UC. 
Follow-up(s): 5 & 10 
months. 
Outcomes: weight, 
SBP, DBP, lipid 






Comorbidity: advanced heart failure. 
Sex: (a) 11 women, 37 men (b) 17 women, 34 men. 
Age mean(SD) years: (a) 53(13) (b) 55(12). 
BMI mean(SD) kg m-2: 30.5(4.2). 
Weight mean(SD) kg: 92.8(13.5). 
(a) Exercise intervention.  Activity: graduated, low-level exercise ≥4 times/week. 
(b) Control group. 
Allocated: (a) 53 (b) 51. 
% dropout: (a) 5.7% (b) 10.52% at 6 months. 
Possible comparisons: PA vs. UC. 







Study, 2003  
[24] 
Location: Finland. 
Comorbidity: impaired glucose tolerance. 
Sex: (a) 176 women, 81men (b) 174 women, 91 men. 
Age mean(SD) years: (a) 55 (7) (b) 55(7). 
BMI mean(SD) kg m-2: (a) 31.4(4.5) (b) 31.1(4.5). 
Weight mean(SD) kg: (a) 86.7(14.0) (b) 85.5 (14.4). 
(a) Lifestyle intervention.  Diet: <30 % kcal from fat, <10 kcal from saturated 
fat, ≥15 g/1000kcal from fibre. 
Activity: MIPA ≥30 min/day.  Other: weight reduction ≥5%. 
(b) Control group. 
Allocated: (a) 265 (b) 257. 
% dropout: (a) 12.8% (b) 21% at 3 years. 
Possible comparisons: D-PA vs. UC. 
Follow-up(s): 12 & 36 
months. 
Outcomes: weight, total 
cholesterol, HDL, TGs, 
HbA1c, FPG, kcal, fat 





Comorbidity: type 2 diabetes. 
(a) Telephone follow-up + Community resource group.  Diet: feedback on 
current dietary behaviour. 
Follow-up(s): 3 & 6 
months. 
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Sex: (a) 45 women, 35 men (b) 46 women, 34 men (c) 
38 women, 42 men, (d) 53 women, 27 men. 
Age mean(SD) years: (a) 57.4(9.4) (b) 59.0(9.6) (c) 
60.5(8.6) (d) 60.6(9.5). 
BMI mean kg m-2: (a) 31.23 (b) 33.27 (c) 34.37 (d) 
34.69. 
Weight mean(SD) kg: (a) 90.26 (b) 96.16 (c) 99.33 (d) 
100.24. 
(b) Telephone follow-up group. Diet: same as (a) 
(c) Community resource group.  Diet: same as (a) 
(d) Basic group.  Diet: same as (a) 
Allocated: (a) 80 (b) 80 (c) 80 (d) 80. 
% dropout: (a) 16.25% (b) 16.25% (c) 6.25% (d) 85% at 6 months. 
Possible comparisons: D vs. UC; Intensive vs. less intensive (D only). 
Outcomes: weight, total 
cholesterol, HbA1c, 






Comorbidity: type 1 or type 2 diabetes. 
Sex: (a) 60 women, 38 men (b) 68 women, 40 men. 
Age mean(SD) years: (a) 61.7(12.1) (b) 63.1(10.5). 
BMI mean kg m-2: (a) 30.4 (b) 30.2. 
Weight mean(SD) kg: not given. 
(a) Intervention. Diet: ≤30% calories from fat, ≤10% kcal from saturated fat. 
(b) Control group. 
Allocated: (a) 106-108 (b) 94-98. 
% dropout: (a) 16.7% (b) 15.3% at 12 months. 
Possible comparisons: D only vs. UC. 
Follow-up(s): 3 & 12 
months. 
Outcomes: weight, total 
cholesterol, HbA1c, 





Comorbidity: binge eating disorder. 
Sex: all women. 
Age mean(SD) years: (a) 89.04(10.15) (b) 87.71(9.58) 
(c) 86.49(9.83). 
BMI mean(SD) kg m-2: (a) 33.50(3.46) (b) 33.16(3.21) 
(c) 32.22(2.97). 
Weight mean(SD) kg: (a) 89.04(10.15) (b) 87.71(9.58) 
(c) 86.49(9.83). 
(a) Dieting treatment.  Diet: reducing fat (40 g/day), increasing complex 
carbohydrates, and eating a variety of foods.  Activity: 4 to 5hr/week at an 
intensity based on training heart rate.  Other:  weight loss averaging 1lb 
(0.454kg)/wk. 
(b) Non-dieting treatment.  Diet: “gradual reductions of fat without feelings of 
deprivation”.  Activity: home-based walking program with gradually attained 
goal of 4-5 h/week. 
(c) Control group. 
Allocated: (a) 79 (b) 78 (c) 62. 
% dropout: (a) 15.2% (b) 16.7% (c) 6.5% at 18 months for (a) and (b) and 6 
months for (c). 
Possible comparisons: D-PA vs. UC. 




Grilo. 2005  
[25] 
Location: USA.  
Comorbidity: Binge Eating Disorder. 
Sex: (a) 29 women, 9 men (b) 32 women, 5 men. 
Age mean(SD) years: (a) 46.0(9.2) (b) 46.0(9.2) (c) 
48.0(8.2). 
BMI mean(SD) kg m-2: (a) 36.0(6.6) (b) 33.4(5.7) (c) 
36.2(6.6). 
Weight mean(SD) kg: not given. 
(a) Behavioural weight loss.  Diet: LEARN Program for Weight Management 
[71]  Activity: LEARN Program for Weight Management [71] 
(b) Cognitive behavioural therapy.  Diet: Overcoming Binge Eating [72]  
Activity: Overcoming Binge Eating [72] 
(c) Control. 
Allocated: (a) 38 (b) 37 (c) 15 
% dropout: (a) 34% (b) 13% (c) 13% 
Possible comparisons: Intensive vs. less intensive (D-PA). 






Comorbidity: CHD risk factors (hypertension, 
hypercholesterolemia) 
Sex: 240 women, 118 men. 
(a) Counselling intervention.  Diet: individualised depending on readiness to 
change.  Activity: individualised depending on readiness to change. 
(b) Control group. 
Allocated: (a) 203 (b) 131. 
Follow-up(s): 6 months. 
Outcomes: weight, total 
cholesterol, LDL, HDL, 
triglycerides, SBP, 
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Age mean(SD) years: (a) 50.1(10.5) (b) 50.41(10.8) 
BMI mean(SD) kg m-2: (a) 33.67(5.4) (b) 34.28(7.0) 
Weight mean(SD) kg: (a) 93.7(17.1) (b) 91.73(17.2) 
% dropout: (a) 38.4% (b) 29% 
Possible comparisons: D-PA vs. UC. 
DBP, fat (% kcal fat), 
overall PA 
(met/min/week). 




Sex: (a) 13 women, 9 men (b) 16 women, 7 men. 
Age mean(SD) years: (a) 53(11) (b) 54(8). 
BMI mean(SD) kg m-2: (a) 32.8(5.4) (b) 34.2(3.2). 
Weight mean(SD) kg: (a) 92.0(14.6) (b) 97.0 (20.9). 
(a) Lifestyle group.  Diet: food provision of DASH diet (18% kcal protein, 55% 
kcal carbohydrate, 27% kcal fat)  Activity: 30-45 minutes of supervised, MIPA, 3 
days/week.   Other: weight loss goal of 4.5kg after 9 weeks. 
(b) Control group. 
Allocated: (a) 22 (b) 23. 
% dropout: (a) 14 % (b) 0%. 
Possible comparisons: D-PA vs. UC. 
Follow-up(s): 12 
months. 
Outcomes: weight, fat 
(% kcal). 
Jones et al. 
2003 [49] 
Location: Canada. 
Comorbidity: type 1 or type 2 diabetes. 
Sex: (a) 233 women, 277 men (b) 257 women, 262 
men. 
Age mean(SD) years: (a1) 54.58 (a2) 55.12 (b1) 54.86 
(b2) 54.60. 
BMI mean kg m-2: (a1) 31.98 (a2) 32.22 (b1) 31.43 
(b2) 31.59. 
Weight mean(SD) kg: not given. 
(a1) Intervention.   Diet: healthy eating focusing on dietary fat reduction.  Other: 
smoking cessation and regular blood glucose monitoring (free strips for self-
testing provided).  
(a2) Intervention.   Diet: healthy eating focusing on dietary fat reduction.  Other: 
smoking cessation and regular blood glucose monitoring (no strips for self-
testing provided). 
(b1) Control group.  Other: free strips for self-testing provided. 
(b2) Control group. 
Allocated: (a1) 260 (a2) 250 (b1) 269 (b2) 250. 
% dropout: 33% overall at 12 months. 
Possible comparisons: D only vs. UC. 
Follow-up(s): 12 
months. 






Comorbidity:  type 2 diabetes. 
Sex: all female. 
Age mean years:  (a) 58.5 (b) 59.8 (c) 59.2. 
BMI mean kg m-2: (a) 36.2 (b) 34.6 (c) 36.2. 
Weight mean kg: (a) 95 (b) 91.9 (c) 95.7. 
(a) Clinic & Community intervention.  Diet: 2-3 dietary goals selected according 
to dietary risk assessment.  Activity: 2-3 activity goals selected according to PA 
assessment. 
(b) Clinical intervention.  Diet: 2-3 same as (a)  Activity: same as (a) 
(c) Control group. 
Allocated: (a) 67 (b) 66 (c) 67. 
% dropout: (a) 19.4% (b) 10.6% (c) 14.9% at 12 months. 
Possible comparisons: D-PA vs. UC; Intensive vs. less intensive (D-PA). 
Follow-up(s): 6 & 12 
months. 
Outcomes: weight, total 
cholesterol, HDL, 






Comorbidity: type 2 diabetes. 
Sex: 35 women, 35 men. 
Age mean(SD) years: 57.6(7.9). 
BMI mean(SD) kg m-2: 34.6(6.8). 
Weight mean(SD) kg: not given. 
(a)  Exercise intervention.  Activity: accumulate 30 min of MIPA most days of 
the week. 
(b) Control group. 
Allocated: (a) 35 (b) 35. 
% dropout: (a) 11.4% (b) 8.6% at 6 months. 
Possible comparisons: PA only vs. UC. 
Follow-up(s): 6 months. 
Outcomes: weight, 
LDL , HDL, TGs, 






Comorbidity: type 2 diabetes. 
Sex: 3 women, 272 men. 
(a) Intervention group.  Diet & Activity: prescriptions from GP (not specified) to 
improve glycemic control. 
(b) Control group. 
Follow-up(s):  12 
months. 
Outcomes: weight, total 
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Age mean(SD) years: (a) 63.9 (8.6) (b) 63.2 (8.3). 
% above ideal weight(SD): (a) 130.6(23.8) (b) 
130.6(193.2). 
Weight mean(SD) kg: not given. 
Allocated: (a) 204 (b) 71. 
% dropout: not given. 
Possible comparisons: D-PA vs. UC. 






Comorbidity: type 2 diabetes. 
Sex: 49 women, 37 men. 
Age mean(SD) years: (a) 52.2(7)  (b) 54.2(6.5). 
BMI mean(SD) kg m-2: (a) 33.95(5.3) (b) 33.5(4.7). 
(a) Intervention group.  Diet: planned energy restriction, ≤ 30% kcal from fat, 
≤10% of kcal saturated fat, ≤300 mg/day dietary cholesterol, fatty acids ≥20% of 
energy unsaturated fat, and increase carbohydrates (e.g. fruits, berries, and 
vegetables).  Activity: increase frequency of exercise sessions to 3-4/week, 
lasting 30-60 min each.  Other: weight reduction, normoglycemia, correction of 
dyslipidemias, and normalisation of elevated blood pressure. 
(b) Usual care group. 
Allocated: (a) 40 (b) 46. 
% dropout: (a) 5% (b) 4% at 15 months. 
Possible comparisons: D-PA vs. UC. 
Follow-up(s): 3, 15 & 
24 months.  
Outcomes: weight, total 
cholesterol, HDL, TGs, 
HbA1c, FPG, kcal, fat 





Comorbidity: Hypertension, elevated blood cholesterol, 
(oesteo)arthritis, diabetes. 
Sex: (a) 232 women, 97 men (b) 226 women, 110 men. 
Number of patients within age  range(%) years: 40 to 
49: (a) 138(42) (b) 129(42); 50 to 59 (a) 138(42) (b) 
141(42); 60 to 69 (a) 52(16) (b) 66(20). 
Number of patients within BMI range(%): 25 to 29.9 
(a) 59(18) (b) 73(22); 30 to 34.5 (a) 119(37) (b) 
107(32); 35 to 39 (a) 69(21) (b) 82(24); 40+ (a)79(24) 
(b) 74(22). 
Weight mean(SD) kg: not given. 
(a) Intervention group.  Diet: increase dietary portion control, <dietary fat, 
>fruits & vegetables.  Activity: increase exercise, increase usual activity. 
(b) Augmented usual care.  Diet & Activity: prescriptions by dietitian based on 
diet and activity recalls. 
Allocated: (a) 329 (b) 336. 
% dropout: (a)  37.8% for weight, 20.08% for other information (b) 31.3% for 
weight, 17.6% for other information at 24 months. 
Possible comparisons: Intensive vs. less intensive (D-PA). 
Follow-up(s):  6, 12, 
18, & 24 months. 
Outcomes:  weight, 







Comorbidity: Breast cancer. 
Sex: (a) 56 Women (b) 29 women. 
Age mean(SD) years: 56.3(8.2). 
BMI mean(SD) kg m-2: 31.0(4.2). 
Weight mean(SD) kg: 84.7(12.6) 
(a) Intervention group.  Diet: 500-1000 kcal/d deficit. 
Activity: one h/d of moderate to vigorous PA. 
(b) Control group. 
Allocated: (a) 56 (b) 29. 
% dropout: (a) 16% (b) 0%. 
Possible comparisons: D-PA vs. UC. 
Follow-up(s): 4 months. 
Outcomes: weight, total 
cholesterol, HDL, TGs, 






Comorbidity: type 2 diabetes. 
Sex: (a) 9 women 27 men (b) 14 women 22 men. 
Age mean(SD) years: (a) 55.9(8.6) (b) 53.7(7.5). 
BMI mean (SD) kg m-2: (a) 32.6(5.7) (b) 32.9(5.5). 
Weight mean(SD) kg: (a) 93.5(20.1) (b) 88.5(18.5). 
(a) Intervention group.  Diet: 50-55% kcal from carbohydrates, ≤30% kcal fat, 
≤10% kcal from saturated fat.  Activity: home based exercise sessions, 3-4 
times/week, 45-55 minutes, intensity at 50-80% of maximum heart rate.  Other: 
After 3 months pharmacological therapy was introduced in patients not able to 
reach treatment goals  
(b) Control group. 
Follow-up(s):  6, 12 & 
18 months. 
Outcomes: weight, 
LDL, HDL, TGs, 
HbA1c, SBP, DBP, 
FPG,  kcal, fat (g), 
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Allocated: (a) 36 (b) 36. 
% dropout (a) 16.7% (b) 19.5% at 18 months. 
Possible comparisons: D-PA vs. UC. 
METs. 
Metz. 2000  
[18] 
Location: USA. 
Comorbidity: 1. hypertension/dyslipidemia or 2. type 2 
diabetes. 
Sex:  1. hypertension/dyslipidemia: (a) 50 women, 43 
men  (b) 50 women 40 men  
2. type 2 diabetes: (a) 31 women, 25 men (b) 38 
women, 25 men. 
Age mean(SD) years: 1. hypertension/dyslipidemia: (a) 
54.5(9.0) (b) 54.4(9.5) 2. type 2 diabetes: (a) 54.6(9.0) 
(b) 54.0(9.9). 
BMI mean (SD) kg m-2: 1. hypertension/ dyslipidemia: 
(a) 33.0(4.9) (b) 32.0(4.2), 2. type 2 diabetes: 
(a) 33.0(4.4) (b) 34.5(4.5). 
Weight mean(SD) kg: not given. 
(a) Intervention group.  Diet: 22% kcal from fat, 58% kcal from carbohydrates, 
20% kcal from protein. 
(b) Usual care group. 
Allocated:  1 Hypertension/dyslipidemia: (a) 93 (b) 90, 2. type 2 diabetes: (a) 56 
(b) 63. 
% dropout : 1. hypertension/dyslipidemia: (a) 15.1% (b) 12.2% at 52 weeks, 2. 
Type 2 diabetes: (a) 26.8% (b) 19.0% at 52 weeks. 
Possible comparisons: D only vs. UC. 
Time of measurements: 
12, 26 & 52 weeks. 
Outcomes: weight, total 
cholesterol, LDL HDL, 
TGs, HbA1c, SBP, 







Comorbidity:  impaired glucose tolerance. 
Sex: (a) 19 women, 16 men (b) 10 women, 22 men. 
Age mean(CI) years: (a) 58.2(41, 75) (b) 57.5(41, 73). 
BMI mean (SD) kg m-2: (a) 30.4(5.6) (b) 29.9 (4.9). 
Weight mean(SD) kg: (a) 83.3(16.6) (b) 85.5(14.2). 
(a) Intervention group.  Diet: 30% kcal from fat, polysaturated to saturated fat 
ratio of 1.0, 50-55% kcal from carbohydrate, 20g/1000kcal of fibre  Activity: 20-
30 min of aerobic activity for 2-3 times/week. 
(b) Control group. 
Allocated: (a) 39 (b) 39. 
% dropout: (a) 38.5% (b) 23.1% at 24 months. 
Possible comparisons: D-PA vs. UC. 
Follow-up(s): 6, 12 & 
24 months. 
Outcomes:  weight, 
total cholesterol, LDL, 
HbA1c, FPG, kcal, fat 






Comorbidity: 1. type 2 diabetes or 2.  family history of 
diabetes. 
Sex: all women. 
Age mean(SD) years: 1. type 2 diabetes:  56.4(8.4),  
2. family history of type 2 diabetes: 42.7(8.4). 
BMI mean kg m-2: 1. type 2 diabetes (a) 36.4(4.7) (b) 
36.3(4.2), 2. family history of type 2 diabetes (a) 
35.0(4.4) (b) 36.1(5.6).  
Weight mean(SD) kg: 1. type 2 diabetes (a) 93.1(13.0) 
(b) 94.4(9.5), 2. family history of type 2 diabetes (a) 
95.3(13.3) (b) 94.5(14.6). 
(a) CAL restriction group.  Diet: 1000-1500 kcal/day, 30% of kcal from fat. 
(b) CAL + fat restriction group.  Diet: same as (a). 
Allocated: 1. type 2 diabetes:  (a) 22 (b) 22, 2. family history of type 2 diabetes: 
(a) 23 (b) 23. 
% dropout: 1. type 2 diabetes: (a) 27% (b) 32%, 2. family history of type 2 
diabetes: (a) 43% (b) 30% at 12 months. 
Possible comparisons: Intensive vs. less intensive (D only). 
Follow-up(s): 16 
weeks, & 12 months. 
Outcomes: weight, total 
cholesterol, HDL, LDL, 




Location: Brisbane, Queensland, Australia. 
Comorbidity: binge eating disorder. 
(a) CBT group.  Diet: “establish regular and healthy eating patterns”. 
(b) CBT & Exercise group.  Diet: same as (a).  Activity: exercise three 
Follow-up(s): 4, 10, & 
16 months. 
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[58] Sex: all women. 
Age mean(SD) years: 45(8.3). 
BMI mean(SD) kg m-2: 36.2(6.5). 
Weight mean(SD) kg: 97.2(17.8). 
 
times/week ≥45 min/session. 
(c) CBT & Maintenance.  Diet: same as (a).  
(d) CBT & Exercise & maintenance.  Diet: same as (a). Activity: same as (b). 
Allocated: (a) 28 (b) 27 (c) 24 (d) 31. 
% dropout: (a) 39.3% (b) 25.9% (c) 16.7% (d) 22.6% at 16 months. 
Possible comparisons: Intensive vs. less intensive (D-PA). 
Outcomes: weight. 
PREMIER 




Sex: (a) 174 women, 94 men (b) 154 women, 115 men 
(c) 172 women, 101 men. 
Age mean(SD) years: (a) 50.2(8.6) (b) 50.2(9.3) (c) 
49.5(8.8). 
BMI mean(SD) kg m-2: (a) 33.0(5.5) (b) 33.3(6.3) (c) 
32.9(5.6). 
Weight mean(SD) kg: not given. 
(a) Established group.  Diet: ≤100 mmol/day of dietary sodium, intake of ≤30 
ml/day alcohol for men and 15 ml/day for women.  Activity: at least 180 
minutes/week of MIPA. Other: weight loss of ≥6.8 kg if BMI ≥ 25 kg/m2. 
(b) Established + DASH diet.  Diet: same as (a) plus ≤ 7% kcal from saturated 
fat, ≤ 25% of kcal from fat.  Activity: ≥180 minutes/week of MIPA.  Other: same 
as (a) 
(c) Advice only group.  Diet: reduced-sodium diet.  Activity: engaging in regular 
MIPA. 
Allocated: (a) 268 (b) 269 (c) 273. 
% dropout: (a) 6% (b) 6% (c) 0% at 18 months. 
Possible comparisons: D-PA vs. UC, Intensive vs. less intensive (D-PA) 
Follow-up(s): 6 & b18 
months. 
Outcomes:  weight, 






Comorbidity: binge eating disorders 
Sex: all female. 
Number of patients within age  range(%) years: (a) 27-
39: n=14, 40-45: n=19, 46-50: n=13(b) 27-39: n=9, -
45: n=14, 46-50: n=13. 
BMI mean kg m-2 (b) 33.8: (a) 31.8. 
Weight mean(SD) kg: (a) 89.36(9.53) (b) 86.64(14.52). 
(a) Intervention group.  Diet: decrease fat intake.  Activity: five 45-minute 
walking sessions/week. 
(b) Waiting list control group. 
Allocated: (a) 59 (b) 39. 
% dropout: (a) 28.3% (b) 7.7% at 6 months. 
Possible comparisons: D-PA vs. WLC. 
Follow-up(s): 6 months. 
Outcomes: weight, kcal, 





Comorbidity: type 2 diabetes. 
Sex: (a) 9 women, 4 men (b) 7 women, 6 men. 
Age mean(SE) years: (a) 60.5(7.8) (b) 60.5(2.1). 
BMI mean(SE) kg m-2: (a) 32.3(1.1) (b) 35.7(1.6). 
Weight mean(SD) kg: (a) 83.0(3.6) (b) 98.2(3.4). 
(a) Intervention group.  Activity: monthly one hour aerobic exercise classes. 
(b) Usual care control group. 
Allocated: (a) 13 (b) 13. 
% dropout: (a) 0% (b) 0% at 12 months. 
Follow-up(s): 6 & 12 
months. 
Outcomes: weight, total 
cholesterol, HDL, TGs, 





Comorbidity: Cardiovascular disease. 
Sex: (a) 17 women, 36 men (b) 9 women, 42 men. 
Age mean(SD) years: (a) 61.8(10.8) (b) 62.8(10.6). 
BMI mean(SD) kg m-2: (a) 31.1(6.8) (b) 29.2(4.8). 
Weight mean(SD) kg: (a) 89 (b) 91.99. 
(a) Special intervention.  Diet: dietician feedback to dietary practice.  Activity: 
individual instructions by case managers. 
(b) Usual care. 
Allocated: (a) 53 (b) 51. 
% dropout: (a) 6% (b) 2%. 
Possible comparisons: D-PA vs. WLC. 
Follow-up(s): 6 months. 
Outcomes: weight, total 
cholesterol, HDL, LDL, 
TGs, SBP, DBP, 
MEDFICTS (indicating 
fat intake), minutes of 
weekly exercise. 
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Comorbidity: one or more other risk factors for type 2 
diabetes. 
Sex: (a) 42 women, 4 men (b) 41 women, 5 men. 
Age mean(SD) years: (a) 49.8(9.3) (b) 47.3(9.5). 
BMI mean(SD) kg m-2: (a) 32.5(3.5) (b) 33.7(3.7). 
Weight mean(SD) kg: (a) 86.2(14.3) (b) 89.4(12.6). 
(a) Internet counselling group.  Diet: 1200 to 1500kcal, 20% kcal from fat.  
Activity: ≥1000kcal/wk of PA. 
(b) Basic internet program.  Diet: same as (a).  Activity: same as (a). 
Allocated: (a) 46 (b) 46. 
% dropout: (a) 0% (b) 0% at 12 months. 









Comorbidity: type 2 diabetes. 
Sex: (a) 7 women, 12 men (b) 9 women, 11 men. 
Age mean(SD) years: (a) 69.3(4.2) (b) 69.5(5.1). 
BMI mean(SD) kg m-2: (a) 29.4(3.7) (b) 30.7(5.4). 
Weight mean(SD) kg: (a) 79.4(14.3) (b) 83.1(18.0) 
(a) Physical exercise programme.  Activity: exercise group sessions, three 
times/week, for 16 weeks. 
(b) Control group. 
Allocated: (a) 19 (b) 20. 
% dropout: (a) 21% (b) 5%. 
Possible comparisons: PA only vs. UC 
Follow-up(s): 4  
months. 
Outcomes: weight, 
HbA1c, treadmill test 
(min). 
Tudor-
Locke 2004  
[52] 
Location: Canada. 
Comorbidity: type 2 diabetes. 
Sex: (a) 12 women, 12 men (b) 9 women, 14 men. 
Age mean(SD) years: (a) 52.8(5.7) (b) 52.5(4.8). 
BMI mean(SD) kg m-2: (a) 34.1(6.1) (b) 32.5(5.0). 
(a) Intervention group.  Activity: self selected activity goals. 
(b) Waiting list control group. 
Allocated: (a) 30 (b) 30. 
% dropout: (a) 33% (b) 4% at 24 weeks. 
Possible comparisons: PA only vs. WLC 
Follow-up(s): 16 & 24 
weeks. 
Outcomes: weight, 
SBP, DBP, total 
cholesterol, LDL HDL 






Comorbidity: coronary heart disease 
Sex: all women. 
Age mean(SD) years: (a) 64(10) (b) 63(11). 
BMI mean(SD) kg m-2: (a) 32(4.2) (b) 32 (5.5). 
Weight mean(SD) kg: (a) 80(10) (b) 79(15). 
(a) Intervention group.  Diet: Reversal diet: <10% kcal from fat, 70 to 75% kcal 
from carbohydrates, 15 to 20% kcal from protein, 5 mg of cholesterol/day.  
Activity: 1 h/day, ≥3 days each week. 
(b) Control group. 
Allocated: (a) 16 (b) 12. 
% dropout: (a) 12.5% (b) 8.3% at 24 months. 
Possible comparisons: D-PA vs. WLC 
Follow-up(s): 4, 12 and 
24 months. 
Outcomes: weight, total 
cholesterol, LDL HDL, 
TGs, SBP, DBP, kcal, 
fat (% kcal), Summary 






Comorbidity: type 2 diabetes. 
Sex: all women. 
Age mean(SD) years: (a) 61.1(8.0) (b) 60.7(7.8). 
BMI mea (SD) kg m-2: (a) 35.1(7.7) (b) 35.6(8.8). 
Weight mean(SD) kg: (a) 92.3(21.2) (b) 93.9(23.8). 
(a) Mediterranean Lifestyle Program. Diet: more bread; more root vegetables, 
green vegetables, and legumes; more fish; less red meat (e.g., beef, lamb, pork), 
to be replaced by poultry; daily fruit; and avoidance of butter and cream, to be 
replaced by olive/canola oil or olive-/canola-based margarine. Activity: 30 min of 
MIPA on most days of the week, once accomplished, 1 hr of MIPA/day. 
(b) Usual care. 
Allocated: (a) 163 (b) 116. 
% dropout: 12% after 6 months. 
Possible comparisons: D-PA vs. UC 
Follow-up(s): 6 months. 
Outcomes: weight, total 
cholesterol, LDL, HDL, 
TGs, Hba1c, SBP, 
DBP,  
METs x duration x days 
baseline adjusted. 
Villareal Location: USA. (a) Intervention group. Diet:  ≈750 kcal/d deficit, ≈30 kcal from fat, 50% kcal Follow-up(s): 6 months. 
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Study ID Participants Interventions Outcomes 
2006 
 [16] 
Comorbidity: Metabolic syndrome. 
Sex: (a) 12 women, 5 men (b) 6 women, 4 men. 
Age mean(SD) years: (a) 69(5) (b) 71(4). 
BMI mean(SD) kg m-2:  (a) 39(5) (b) 39(5). 
Weight mean(SD) kg: (a) 100(14) (b) 103(20). 
from carbohydrate, 20% kcal from protein. Activity: Exercise-training on 3 
days/week for 90 min. Other: 1.5% loss of body weight/week, 10% weight loss 
after 6 months. 
(b) Control group. 
Allocated: (a) 17 (b) 10. 
% dropout: (a) 12% (b) 10%. 
Possible comparisons: D-PA vs. WLC 
Outcomes: weight, 
LDL, walking speed 
(m/min). 
Wing 1985  
[44] 
Location: USA. 
Comorbidity: type 2 diabetes. 
Sex: 33 women, 20 men. 
Age mean(SE) years: 55.1(7.28). 
BMI mean(SE) kg m-2: 34.8(5.10). 
Weight mean(SE) kg: 96.4(2.3). 
(a) Behaviour modification condition.  Diet: self-selected kcal goals, <four 
servings of high sugar foods/week, > fiber intake.  Activity: 1000 kcal 
expenditure/week. 
(b) Nutrition education condition. Diet: “…given calorie goal at a level 
comparable to […] the behaviour modification condition”. 
(c) Standard care condition. 
Allocated: 53 overall. 
% dropout: 6% overall at 62 weeks. 
Possible comparisons: D-PA vs. WLC 
Follow-up(s): 3 & 12 
months. 
Outcomes: weight, total 
cholesterol, HDL, TGs, 




Comorbidity: type 2 diabetes. 
Age mean(SD) years: (a) 51.2(7.3) (b) 53.6(7.7). 
BMI mean(SD) kg m-2: (a) 36.64(5.77) (b) 
35.68(5.76). 
Weight mean(SD) kg: (a) 102.97(18.5) (b) 
96.84(19.69). 
(a) Alone condition. Diet: 1,200-1,500 kcal/day. Activity: 1,000 kcal/week 
expenditure through exercise. Other: weight loss reward: $2for every lb lost. 
(b) Together condition. Diet: same as (a). Activity: same as (a) Other: same as 
(a). 
Allocated: (a) 25 (b) 24. 
% dropout: (a) 8% (b) 17% at 12 months. 
Possible comparisons: Intensive vs. Less intensive (D-PA). 
Follow-up(s): 20 
weeks, 12 months. 
Outcomes: weight, 
HbA1c, FPG. 
Wing 1998  
[45] 
Location: USA. 
Comorbidity: family history of type 2 diabetes. 
Sex: 122 women, 32 men. 
Age mean(SD) years:: (a) 45.0(4.7) (b) 46.4(4.5) (c) 
46.3(3.8) (d) 45.3(4.9). 
BMI mean(SD) kg m-2: (a) 36.1(4.1) (b) 36.0(3.7) (c) 
35.7(4.1) (d) 36.0 (5.4). 
Weight mean(SD) kg: (a) 99.6 (13.0) (b) 99.3(15.3) (c) 
98.7(15.9) (d) 97.4(16.0). 
(a) Diet condition. Diet: 800-1000 kcal/day, 20% of kcal from fat, gradually 
made more flexible with calorie goals of 1200-1500 kcal/day. 
(b) Exercise condition. Activity: gradual increase activity to 1500 kcal/week 
through 5 days/week, increases of 250 kcal/week. 
(c) Diet-plus-exercise condition. Diet: same as (a). Activity: same as (b). 
(d) Usual care 
Allocated: (a) 37 (b) 37 (c) 40 (d) 40. 
% dropout: (a) 5% (b) 16% (c) 20% (d) 23% at 24 months. 
Possible comparisons: D-PA vs. UC, D only vs. UC, PA only vs. UC 
Follow-up(s): 6, 12, & 
24 months. 
Outcomes: weight, 
LDL, HDL, TGs, 
HbA1, SBP, DBP FPG, 
kcal, fat (% kcal), 
kcal/week. 
Note. D-PA = Diet &  PA intervention, D only = diet only intervention, DBP = diastolic blood pressure, FHQ = Food Habit Questionnaire, FPG = fasting plasma glucose, HbA1c 
= haemoglobin A1C, HDL = High-density lipoprotein cholesterol, Kcal – kilocalories, LDL = Low-density lipoprotein cholesterol, LTPA = leisure time physical activity, min = 
minutes, METs = metabolic equivalent of task, MIPA = moderate intensity physical activity, PA only = Physical activity only interventions, PASE = physical activity scale for 
the elderly, SBP = systolic blood pressure, TGs = tryglycerides, UC = Usual care, WLC = Waiting list control. 
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Table 2  Intervention effects (95% CIs) on calorie intake, fat intake  and PA  in diet and PA, diet only and PA only interventions at 3, 6, 12, 18, 24, and 36 months. 
 Diet + PA  Diet only  PA only 
 kcal intake  Fat intake  PA  kcal intake   Fat intake  PA ns 
Month MD CI  SMD CI  SMD CI  MD CI  SMD CI  SMD CI 
3  -11.6 -160, 137  -0.5** -0.9, -0.2  0.5** 0.3, 0.8  -15 -382, 352  0 -0.3, 0.4  0.8** -0.1, 1.6 
6  -100** -238, 39  -0.5** -0.9, 0  0.3** 0.1, 0.6  -360 -656, -64  -0.4** -1.0, 0.2  0.7* 0.4, 0.9 
12  -138 -190, -86  -0.3** -0.5, -0.2  0.5** 0.2, 0.7  -266 -389, -143  -0.6** -0.9, -0.2  0.7 0.4, 1.1 
24  -116* -264, 32  -1.0** -1.7, -0.4  0.4** 0, 0.8  -519 -811, -227  -0.8 -1.3, -0.3  0.2 -0.3, 0.7 
36  -107 -196, -18  -0.2 -0.4, 0  0.0 -0.2, 0.2  no data  no data  no data 
Note: I2  * >25%, ** >50%, kcal = kilocalorie, MD = mean difference, SMD = standardised mean difference, CI = confidence interval. 
N studies (participants) for MD kcal intake in D-PA trials: 4 (530), 8 (990), 10 (3418), 3 (140), and 1 (434) at 3, 6, 12, 24, and 36 months. 
N studies (participants) for SMD in fat intake in D-PA trials: 5 (624), 9 (1469), 11 (3514), 3 (142), and 1 (434) at 3, 6, 12, 24, and 36 months. 
N studies (participants) for SMD for PA in D-PA trials:  6 (705), 12 (1757), 10 (1484), 4 (576), and 1 (434) at 3, 6, 12, , 24, and 36 months. 
N studies (participants) for MD kcal intake in D-only trials: 1 (31), 1 (67), 5 (336), and 1 (66) at 3, 6, 12, and 24 months. 
N studies (participants) for SMD in fat intake in D-only trials: 1 (67), 3 (298), and 1 (66) at 6, 12, and 24 months. 
N studies (participants) for SMD in PA in PA-only trials: 2 (86), 5 (303), 3 (142), and 1 (62) at 3, 6, 12, and 24 months. 
 
 
Table 3  Mean differences (95% CIs) in weight changes from meta-analyses of RCTs comparing diet and PA, diet only and PA only interventions against usual care or waiting 
list control groups, and RCTs comparing intensive diet and PA, and intensive diet only interventions again less intensive diet and PA and less intensive diet only interventions. 
 Diet & PA  Diet only  PA only  Intensive diet & PA  Intensive diet 
Month MD CI  MD CI  MD CI  MD CI  MD CI 
3  -2.8** -4.4, -1.2  -2.9** -4.7, -1.2  -0.1 -2.0, 1.8  -1.3 -2.4, -0.2  -1.2** -2.7, 0.3 
6  -3.5** -5.1, -1.9  -4.0** -6.7, -1.2  -2.7** -4.8, -0.6  -0.9* -1.7, 0.0  0 -2.0, 2.0 
12  -2.9** -4.3, -1.5  -2.3** -3.8, -0.8  -0.3 -2.2, 1.6  -1.2* -2.7, 0.4  -3.1 -5.5, -0.6 
24  -2.8 -3.5, -2.0  -1.8 -4.8, 1.2  1.3 -1.0, 3.6  -0.3 -1.4, 0.7  No data 
36  -2.6 -3.6, -1.6  No data  No data  No data  No data 
Note: I2   * >25%, ** >50%, MD = mean difference, CI = confidence interval. 
N studies (participants) for diet and PA trials: 8 (850), 15 (4056), 15 (4048), 3 (572), 6 (730) and 1 (434) at 3, 6, 12, 18. 24, and 36 months 
N studies (participants) for D-only trials: 4 (450), 6 (486), 6 (1107), and 1 (66) at 3, 6, 12 and 24 months. 
N studies (participants) for PA-only trials: 2 (86), 5 (319), 2 (83), and 1 (62) at 3, 6, 12 and 24 months. 
N studies (participants) for intensive diet and PA trials: 5 (264), 7 (1323), 7 (750), 4 (957), and 2 (488) at 3, 6, 12, 18 and 24 months. 




Table 5 Mean differences (95% CIs) of total cholesterol (mmol/l), LDL cholesterol (mmol/l) HDH cholesterol (mmol/l), triglycerides (mmol/l), glycosylated haemoglobin 
(HbA1c), blood pressure (mmHg) and glucose (mmol/l) changes over time from meta-analyses of D-PA interventions 
 3 months  6 months  12 months  24 months  36 months 
Outcome MD CI  MD CI  MD CI  MD CI  MD CI 
Cholesterol  -0.3 -0.4, -0.1  -0.1* -0.3, 0.1  -0.1* -0.3, 0.0  -0.1 -0.2, 0.0  -0.2 -0.4, 0.0 
LDL cholesterol  -0.1 -0.2, 0.1  -0.1 -0.2, 0.0  -0.2** -0.3, 0.0  0.1 -0.1, 0.2  No data 
HDL cholesterol 0.0 -0.1, 0.0  0.0 0.0, 0.0  0.0 0.0, 0.0  0.0 0.0, 0.1  0.0 0.0, 0.1 
Triglycerides -0.2 -0.4, -0.1  -0.1* -0.3, 0.0  -0.3** -0.5, -0.1  -0.2 -0.4, -0.1  -0.1 -0.2, 0.0 
HbA1c% -0.8 -1.9, 0.3  -0.2* -0.5, 0.1  -0.2 -0.4, -0.1  0.0 -0.2, 0.2  -0.2 -0.3, -0.1 
DBP -1.9 -3.3, -0.6  -2.5 -3.3, -1.6  -2.5 -3.2, -1.9  -2.7 -3.5, -1.9  -3.25 -4.4, -2.1 
SBP -5.0 -7.0, -2.9  -4.6** -6.8, -2.4  -3.7* -5.1, -2.2  -3.0 -4.1, -1.9  -2.7 -4.1, -1.3 
FPG  0.0 -1.0, 1.0  -0.4 -0.5, -0.2  0.1** -0.3, 0.2  0.1** -0.5, 0.4  -0.1 -0.2, 0.0 
Note: I2  * >25%, ** >50%, MD = mean difference, CI = confidence interval, LDL cholesterol = low density lipoprotein cholesterol, HDL cholesterol = high density lipoprotein  
cholesterol, DBP = diastolic blood pressure, SBP = systolic blood pressure, FPG = fasting plasma glucose. 
N studies (participants) for total cholesterol: 5 (700), 7 (1017), 10 (1537), 5 (730), and 1 (434) at 3, 6, 12, 24 and 36 months. 
N studies (participants) for LDL cholesterol: 5 (698), 6 (897), 8 (900), and 3 (430) at 3, 6, 12, , 24 months. 
N studies (participants) for HDL cholesterol: 5 (700), 7 (1014), 10, (1532), 1 (63), and 1 (434) at 3, 6, , 24, 36 months. 
N studies (participants) for HbA1c: 2 (359), 5 (583), 6 (1123), 1 (61), 2 (113), and 1 (459) at 3, 6, 12, 24, and 36 months. 
N studies (participants) for triglycerides: 5 (701), 6 (898), 9 (1430), 4 (676), and 1 (434) at 3, 6, 12, , 24, and 36 months. 
N studies (participants) for DBP: 4 (587), 7 (1166), 9 (3462), 4 (2303), and 1 (2161) at 3, 6, 12, , 24, and 36 months. 
N studies (participants) for SBP: 4 (587), 7 (1175), 9 (3462), 4 (2303), and 1 (2161) at 3, 6, 12, , 24, and 36 months. 
N studies (participants) for FBP: 1 (241), 3 (198), 6 (804), (3 (623), and 1 (434) at 3, 6, 12, , 24, and 36 months.
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Table 6 Mean difference (95% CIs) of total cholesterol (mmol/l), LDL cholesterol (mmol/l) HDH cholesterol (mmol/l), triglycerides (mmol/l), glycosylated haemoglobin 
(HbA1c), blood pressure (mmHg) and glucose (mmol/l) changes over time from meta-analyses of D-only interventions 
 3 months  6 months  12 months  24 months  
Outcome MD CI  MD CI  MD CI  MD CI  
Cholesterol  -0.3 -0.4, -0.2  -0.3** -0.6, 0.1  -0.1** -0.4, 0.2  -0.3 -0.6, 0.0  
LDL cholesterol -0.1 -0.3, 0.0  -0.1** -0.4, 0.3  -0.1** -0.5, 0.3  -0.2 -0.5, 0.1  
HDL cholesterol 0.0 -0.03, 0.02  0.0** -0.1, 0.1  0.1 0.0, 0.1  0.0 -0.1, 0.1  
Triglycerides -0.3* -0.6, -0.1  -0.3 -0.5, 0.0  -0.1 -0.4, 0.2  -0.3 -1.3, 0.6  
HbA1c% -0.2** -0.5, 0.1  -0.3** -0.7, 0.0  -0.1 -0.2, 0.0  0.00 -0.2, 0.2  
DBP -0.8 -2.2, 0.5  -1.8 -3.5, -0.1  -0.9 -2.4, 0.5  1.0 -2.8, 4.8  
SBP -2.9 -5.1, -0.7  -4.2 -7.9, -0.5  -0.3 -2.9, 2.3  0.7 -4.6, 6.0  
FPG  -0.8 -2.0, 0.4  -0.3 -0.5, -0.1  -0.3 -1.1, 0.5  0.1 -0.3, 0.5  
Note: I2  * >25%, ** >50%, MD = mean difference, CI = confidence interval, LDL cholesterol = low density lipoprotein cholesterol, HDL cholesterol = high density lipoprotein  
cholesterol, DBP = diastolic blood pressure, SBP = systolic blood pressure, FPG = fasting plasma glucose. 
N studies (participants) for total cholesterol: 3 (458), 3 (329), 5 (496), and 1 (66) at 3, 6, 12, and 24 months.  
N studies (participants) for LDL cholesterol: 2 (185), 3 (329), 4 (332), and 1 (66) at 3, 6, 12, and 24 months. 
N studies (participants) for HDL cholesterol: 2 (285), 3 (325), 4, (332), and 1 (66) at 3, 6, 12, and 24 months. 
N studies (participants) for triglycerides: 2 (285), 3 (329), 4 (332), and 1 (66) at 3, 6, 12, and 24 months. 
N studies (participants) for HbA1c: 4 (602), 4 (464), 3 (411), and 1 (66) at 3, 6, 12, and 24 months. 
N studies (participants) for DBP: 2 (285), 3 (360), 3 (312), and 1 (66) at 3, 6, 12, and 24 months. 
N studies (participants) for SBP: 2 (285), 3 (360), 3 (312), and 1 (66) at 3, 6, 12, and 24 months. 
N studies (participants) for FBP: 2 (285), 3 (329), 4 (332), and 1 (66) at 3, 6, 12, and 24 months.
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Table 7 Mean difference (95% CIs) of total cholesterol (mmol/l), LDL cholesterol (mmol/l) HDH cholesterol (mmol/l), triglycerides (mmol/l), glycosylated haemoglobin 
(HbA1c), blood pressure (mmHg) and glucose (mmol/l) changes over time from meta-analyses of PA-only interventions 
 3 months  6 months  12 months  24 months  
Outcome MD CI  MD CI  MD CI  MD CI  
Cholesterol  0.1 -0.3, 0.5  -0.1 -0.2, 0.2  -0.1 -0.4, 0.2  0.2 -0.1, 0.4  
LDL cholesterol  0.0 -0.3, 0.3  -0.1 -0.3, 0.1  -0.1 -0.4, 0.1  0.2 -0.1, 0.5  
HDL cholesterol 0.1 -0.1, 0.2  0.1 0.0, 0.2  0.1 0.0, 0.1  0.0 -0.1, 0.1  
Triglycerides 0.0 -0.9, 0.9  -0.1 -0.6, 0.4  0.0 -0.4, 0.4  -0.2 0.8, 0.5  
HbA1c% 0.0 -1.7, 1.6  -0.2 -0.6, 0.1  -0.1 -0.8, 0.5  0.0 -0.2, 0.2  
DBP 0.4 -3.6, 4.4  -1.7 -4.6, 1.2  -4.0 -8.7, 0.7  0.0 -4.0, 4.0  
SBP -1.7 -7.9, 4.6  -3.1 -7.7, 1.74  0.0 -6.8, 6.8  2.4 -4.1, 8.7  
FPG  0.7 -0.4, 1.8)  -0.1 -0.4, 0.2  0.0 -0.3, 0.3  0.2 -0.2, 0.6  
Note: I2  * >25%, ** >50%, MD = mean difference, CI = confidence interval, LDL cholesterol = low density lipoprotein cholesterol, HDL cholesterol = high density lipoprotein  
cholesterol, DBP = diastolic blood pressure, SBP = systolic blood pressure, FPG = fasting plasma glucose. 
N studies (participants) for total cholesterol: 1 (47), 3 (138), 3 (147), and 1 (62) at 3, 6, 12, and 24 months.  
N studies (participants) for LDL cholesterol: 1 (47), 2 (105), 2 (113), and 1 (62) at 3, 6, 12, and 24 months. 
N studies (participants) for HDL cholesterol: 1 (47), 3 (134), 3 (143), and 1 (62) at 3, 6, 12, and 24 months. 
N studies (participants) for triglycerides: 1 (47), 3 (137), 2 (147), and 1 (62) at 3, 6, 12, and 24 months. 
N studies (participants) for HbA1c: 1 (39), 3 (141), 2 (91), and 1 (62) at 3, 6, 12, and 24 months. 
N studies (participants) for DBP: 1 (47), 3 (196), 1 (57), and 1 (62) at 3, 6, 12, and 24 months. 
N studies (participants) for SBP: 1 (47), 3 (196), 1 (57), and 1 (62) at 3, 6, 12, and 24 months. 
N studies (participants) for FBP: 1 (47), 2 (91), 2 (85), and 1 (62) at 3, 6, 12, and 24 month. 
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Databases searched:
Medline (1950 – January 2008) n=1377
Embase (1980 – January 2008) n=4963
PsycInfo (1872 – January 2008) n=1816
Journals searched:
International Journal of Obesity (1987 – May 2006)
Obesity research (2000 – May 2006)
International Journal of Behavioural Medicine 
(2000 – May 2006)
7658 potentially relevant references
+ journal articles
145 studies retrieved for more 
detailed evaluation
44 studies identified suitable 
for the systematic review
7513 papers excluded due to lack of suitability of 
study design, type of intervention or population
101 papers excluded for reasons such as:
• BMI too low 
• No behavioural outcome 
• No risk factor
• No weight variables 
• Sample too young
 





Figure 2: MD in weight change between intervention and control participants for diet and 
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